Skip to main content

Coronavirus: Clinical Trials

Question for Department of Health and Social Care

UIN 104732, tabled on 16 October 2020

To ask the Secretary of State for Health and Social Care, what steps he is taking to mitigate the effect of the covid-19 outbreak on clinical trials in (a) dementia and (b) other medical conditions.

This answer is the replacement for a previous holding answer.

Answered on

27 October 2020

The Government remains strongly committed to supporting research into dementia and the United Kingdom research community is playing a significant role in the global effort to find a cure or a major disease-modifying treatment by 2025.

The Department’s National Institute for Health Research (NIHR) published a framework in May to support the restarting of research paused due to COVID-19 at the following link:

https://www.nihr.ac.uk/documents/restart-framework/24886

The NIHR is supporting the research community to amend study protocols for COVID-19 security. Last week the NIHR published guidance that NIHR-funded research staff should not be deployed to frontline duties except in exceptional circumstances.

Answered by

Department of Health and Social Care
Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.